Roche, NIH funding ban, Galapagos, Wegovy


Thank you for reading this post, don't forget to subscribe!

Need to keep on prime of the science and politics driving biotech as we speak? Join to get our biotech publication in your inbox.

Good morning, as we speak we take a look at seemingly conflicting messaging popping out of the NIH, the departure of a key government at  Galapagos, and extra.

The necessity-to-know this morning

  • Roche introduced it’s going to would make investments $50 billion in new and expanded amenities within the U.S. over the subsequent 5 years, making it the newest pharma firm to make such an announcement because the Trump administration requires the trade to take a position extra within the nation.

NIH lays out new phrases for grants to universities

The NIH will begin banning new grants to any universities which have DEI packages or boycott Israeli corporations, in an escalation of the Trump administration’s use of analysis funding as leverage.

STAT+ Unique Story

STAT+





This text is unique to STAT+ subscribers

Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.

Have already got an account? Log in

View All Plans

To learn the remainder of this story subscribe to STAT+.

Subscribe